Eczema drug gets extended test for Long-Term relief
Disease control
Recruiting now
This study aims to find out if an investigational drug called APG777 is safe and effective for long-term use in people with moderate-to-severe eczema (atopic dermatitis). It is open only to people who have already completed a previous study with APG777. The main goal is to monito…
Phase: PHASE2 • Sponsor: Apogee Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC